Feasibility study of MyPain Compass and MyPain Impact
Research type
Research Study
Full title
A single arm study investigating the feasibility of delivering a clinician guided online pain management programme (MyPain Compass) while using MyPain Impact for online communication and recording outcomes, in chronic pain patients
IRAS ID
149837
Contact name
Amanda Williams
Contact email
Sponsor organisation
Department of Research & Development , Chelsea and Westminster hospital
Clinicaltrials.gov Identifier
ISRCTN , 31114
Duration of Study in the UK
0 years, 9 months, 28 days
Research summary
It is estimated that 13% of UK adults live with chronic pain. Increasing evidence supports the use of online applications for chronic health conditions with small to moderate effects reported for pain management. MyPain Compass is an online pain management programme (PMP) with additional features to existing PMPs.
This replicated single-case design feasibility study aims to assess if we can deliver and evaluate MyPain Compass (PMP) and MyPain Impact (online communication and data recording system) for patients with chronic pain conditions, and explore initial evidence of its impact on daily pain and physical activity levels.
We will recruit 15 adults with a chronic pain condition from NHS outpatient pain or community clinics and randomise them to start MyPain Compass after baseline periods of 10,15 or 20 days. They will be guided through 12 modules over approximately 12 weeks and have a weekly 20 minute video-conference (using MyPain Impact) or telephone call with a clinician. The computer software will record how participants have used MyPain Compass. Daily pain and physical activity scores will be recorded during baseline and participation in the programme. Participants will also complete online questionnaires (via MyPain Impact) at the start, midpoint and end of the programme to record self-efficacy, psychological status and general health as well as what they think of MyPain Compass. Up to 7 participants will be telephone interviewed to discuss their experience of using MyPain Compass (midpoint and at the end). Clinicians will complete an online questionnaire to capture their views on the acceptability of MyPain Compass.
The study will last 10 months (April 2016 to January 2017) with an additional 3 months to identify sites and secure approvals (January-March 2016). It is jointly funded by My Pain Ltd and Chelsea and Westminster NHS Foundation Trust.
REC name
London - Fulham Research Ethics Committee
REC reference
16/LO/0272
Date of REC Opinion
24 Mar 2016
REC opinion
Further Information Favourable Opinion